Salarius Pharmaceuticals Competitors and Similar CompaniesClear all
Salarius Pharmaceuticals's competitors and similar companies include Medicenna Therapeutics, MetaStat, ImmunoCellular Therapeutics and Bellerophon Therapeutics.
 Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. |  MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs. |  ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers. |  Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 2012 | Founding Date 2010 | Founding Date 2006 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ | Locations HQ | Locations Boston, US HQ | Locations Calabasas, US HQ | Locations Warren, US HQ |
Employees | Employees 1225% decrease | Employees 7 | Employees 6 | Employees 357% decrease | Employees 1715% decrease |
Valuation ($) | Valuation ($) 2.4 m | Valuation ($) 122.2 m | Valuation ($) 20.6 k | Valuation ($) 15.9 m | Valuation ($) 440.4 k |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $23.3k (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($5.6m) (FY, 2024) | Net income ($25.5m) (FY, 2024) | Net income ($3.2m) (FY, 2018) | Net income ($14.3m) (FY, 2017) | Net income ($19.8m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised $ 350k | Total funding raised $ 32.5m | Total funding raised $ 80m |
For sources of this data, please see the company profile
View Company Profiles
Medicenna Therapeutics
HQ
Employees
7
Medicenna Therapeutics is an immunotherapy company focused on oncology.
View companyMetaStat
HQ
Boston, US
Employees
6
MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
View companyImmunoCellular Therapeutics
HQ
Calabasas, US
Employees
3
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
View companyBellerophon Therapeutics
HQ
Warren, US
Employees
17↓ 15% decrease
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
View company